Rights and permissions
About this article
Cite this article
Imatinib mesylate normalised bone marrow fibrosis during treatment of chronic myeloid leukaemia. Inpharma Wkly. 1327, 19 (2002). https://doi.org/10.2165/00128413-200213270-00044
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200213270-00044